Reference:
1. Packard KA, Backes JM, Lenz TL, Wurdeman RL, Destache CJ, Hilleman DE. Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease. Available at: http://www.medscape.com/viewarticle/446793_4.
2. Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. Endocr Pract 2002;8:96-101.
3. Jen SL, Chen JW, Lee WL, Wang SP. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study. Zhonghua Yi Xue Za Zhi 1997;59:217-24.
Keywords:
-